NASDAQ:OSAP ProSomnus (OSAP) Stock Price, News & Analysis → Biotech's Best Kept Secret: Potential 46,751% Gain (From Behind the Markets) (Ad) Free OSAP Stock Alerts $0.03 +0.01 (+42.55%) (As of 05/31/2024 ET) Add Compare Share Share Today's Range$0.03▼$0.0450-Day Range N/A52-Week Range$0.02▼$5.10Volume780 shsAverage Volume77,237 shsMarket Capitalization$582,699.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsTrendsStock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsTrends Get ProSomnus alerts: Email Address Ad Behind the MarketsBiotech's Best Kept Secret: Potential 46,751% GainThe world's #1 biotech investor has been praising this stock since it was just $18.56. Even though it's rocketed 266% this year, he's now recommending a different biotech entirely!Get the name of the stock here >>> About ProSomnusProSomnus, Inc. operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea. The company sells its products to sleep dentists, sleep physicians, primary care providers, otolaryngologists, and other integrated healthcare service providers through a direct sales force. ProSomnus, Inc. is headquartered in Pleasanton, California.Read More OSAP Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OSAP Stock News HeadlinesMay 30 at 6:00 AM | globenewswire.comProSomnus Contributes Two Scientific Abstracts for Presentation at SLEEP 2024, A Joint Meeting of the American Academy of Sleep Medicine and the Sleep Research SocietyMay 16, 2024 | globenewswire.comProSomnus Announces Strong First Quarter 2024 Revenue GrowthMay 13, 2024 | globenewswire.comProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual MeetingSee More Headlines Receive OSAP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ProSomnus and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/27/2024Today6/02/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:OSAP CUSIPN/A CIK1934064 Webwww.prosomnus.com Phone844-537-5337FaxN/AEmployees136Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.56) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-24,090,000.00 Net Margins-87.14% Pretax Margin-87.14% Return on EquityN/A Return on Assets-106.30% Debt Debt-to-Equity RatioN/A Current Ratio1.00 Quick Ratio0.86 Sales & Book Value Annual Sales$27.65 million Price / Sales0.02 Cash FlowN/A Price / Cash FlowN/A Book Value($2.33) per share Price / Book-0.01Miscellaneous Outstanding Shares17,394,000Free Float16,055,000Market Cap$582,699.00 OptionableN/A Beta0.60 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Leonard Liptak (Age 49)Co-Founder, CEO & Director Comp: $965.35kMr. Sung Kim (Age 42)Co-Founder & CTO Comp: $454.63kMs. Laing F. RikkersCo-founder & Executive ChairmanMr. Brian B. Dow (Age 55)CFO & Corporate Secretary Dr. John E. Remmers M.D.Chief ScientistMs. Heather WhalenVice President of Global Marketing ServicesDr. Shouresh Charkhandeh D.D.S.Global Scientific Committee ChairMore ExecutivesKey CompetitorsDynatronicsNASDAQ:DYNTNemaura MedicalNASDAQ:NMRDAcutus MedicalNASDAQ:AFIBBluejay DiagnosticsNASDAQ:BJDXAethlon MedicalNASDAQ:AEMDView All Competitors OSAP Stock Analysis - Frequently Asked Questions How have OSAP shares performed in 2024? ProSomnus' stock was trading at $0.1176 at the beginning of 2024. Since then, OSAP stock has decreased by 71.5% and is now trading at $0.0335. View the best growth stocks for 2024 here. How were ProSomnus' earnings last quarter? ProSomnus, Inc. (NASDAQ:OSAP) posted its quarterly earnings results on Wednesday, March, 27th. The company reported ($0.42) EPS for the quarter. The company earned $7.84 million during the quarter. How do I buy shares of ProSomnus? Shares of OSAP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:OSAP) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaHow Biden has already won 2024Porter & CompanyThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProSomnus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.